In animal models of AD with Aβ injections, the effect of CBD proves to be anti-inflammatory, acting through the reduction in mRNA expression of glial fibrillary acidic protein (GFAP), NO, and release of IL-1β [136], and through the activity on the PPAR-γ receptor [110]. Here, GFAP is linked to Alzheimer disease.